Neurobiology of Aging
Volume 28, Issue 9 , Pages 1374-1380 , September 2007

Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE

  • Behnosh F. Björk

      Affiliations

    • Karolinska Institutet, Department NVS, Division of KI-Alzheimer Disease Research Center, SE-141 57 Huddinge, Sweden
    • ,
  • Hagit Katzov

      Affiliations

    • Karolinska Institutet, Centre for Genomics and Bioinformatics (CGB), SE-171 77 Stockholm, Sweden
    • ,
  • Patrick Kehoe

      Affiliations

    • Department of Clinical Science at North Bristol, University of Bristol, Frenchay Hospital, Bristol BS16 1LE, UK
    • ,
  • Laura Fratiglioni

      Affiliations

    • Karolinska Institutet, Department Neurotec, Division of Geriatric Epidemiology, SE-113 82 Stockholm, Sweden
    • ,
  • Bengt Winblad

      Affiliations

    • Karolinska Institutet, Department NVS, Division of KI-Alzheimer Disease Research Center, SE-141 57 Huddinge, Sweden
    • ,
  • Jonathan A. Prince

      Affiliations

    • Karolinska Institutet, Centre for Genomics and Bioinformatics (CGB), SE-171 77 Stockholm, Sweden
    • ,
  • Caroline Graff

      Affiliations

    • Karolinska Institutet, Department NVS, Division of KI-Alzheimer Disease Research Center, SE-141 57 Huddinge, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 8 585 83619; fax: +46 8 585 83610.

Received 9 December 2005 ,Revised 12 June 2006 ,Accepted 19 June 2006.

References 

  1. Abraham R, Myers A, Wavrant-DeVrieze F, Hamshere ML, Thomas HV, Marshall H, et al. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet. 2001;109(6):646–652
  2. Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S, et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science. 2000;290(5500):2302–2303
  3. Bian L, Yang J, Guo T, Sun Y, Duan S, Chen W, et al. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese. Neurology. 2004;63(2):241–245
  4. Blomqvist ME, Chalmers K, Andreasen N, Bogdanovic N, Wilcock GK, Cairns NJ, et al. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Neurobiol Aging. 2005;26(6):795–802
  5. Blomqvist ME, Silburn PA, Buchanan DD, Andreasen N, Blennow K, Pedersen NL, et al. Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease. Neurogenetics. 2004;5(2):115–119
  6. Boussaha M, Hannequin D, Verpillat P, Brice A, Frebourg T, Campion D. Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease. Neurosci Lett. 2002;329(1):121–123
  7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921–923
  8. Edbauer D, Willem M, Lammich S, Steiner H, Haass C. Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). J Biol Chem. 2002;277(16):13389–13393
  9. Edland SD, Wavrant-De Vriese F, Compton D, Smith GE, Ivnik R, Boeve BF, et al. Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE). Neurosci Lett. 2003;345(1):21–24
  10. Ertekin-Taner N, Allen M, Fadale D, Scanlin L, Younkin L, Petersen RC, et al. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease. Hum Mutat. 2004;23(4):334–342
  11. Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, et al. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science. 2000;290(5500):2303–2304
  12. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA. 2003;100(7):4162–4167
  13. Farris W, Mansourian S, Leissring MA, Eckman EA, Bertram L, Eckman CB, et al. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol. 2004;164(4):1425–1434
  14. Florez JC, Wiltshire S, Agapakis CM, Burtt NP, de Bakker PI, Almgren P, et al. High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4206 people. Diabetes. 2006;55(1):128–135
  15. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349:704–706
  16. Gu HF, Efendic S, Nordman S, Ostenson CG, Brismar K, Brookes AJ, et al. Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels. Diabetes. 2004;53(8):2137–2142
  17. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000;26(2):163–175
  18. Karamohamed S, Demissie S, Volcjak J, Liu C, Heard-Costa N, Liu J, et al. Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes. 2003;52(6):1562–1567
  19. Kurochkin IV, Goto S. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 1994;345(1):33–37
  20. Lagergren M, Fratiglioni L, Hallberg IR, Berglund J, Elmstahl S, Hagberg B, et al. A longitudinal study integrating population, care and social services data. The Swedish Narional study on Aging and Care (SNAC). Aging Clin Exp Res. 2004;16(2):158–168
  21. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, et al. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet. 2002;70(4):985–993
  22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939–944
  23. Miller BC, Eckman EA, Sambamurti K, Dobbs N, Chow KM, Eckman CB, et al. Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA. 2003;100(10):6221–6226
  24. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41(4):479–486
  25. Myers A, Holmans P, Marshall H, Kwon J, Meyer D, Ramic D, et al. Susceptibility locus for Alzheimer's disease on chromosome 10. Science. 2000;290(5500):2304–2305
  26. Nowotny P, Hinrichs AL, Smemo S, Kauwe JS, Maxwell T, Holmans P, et al. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme. Am J Med Genet B Neuropsychiatr Genet. 2005;136(1):62–68
  27. Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, et al. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA. 1997;278(15):1237–1241
  28. Pericak-Vance MA, Bebout JL, Gaskell PC, Yamaoka LH, Hung WY, Alberts MJ, et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet. 1991;48(6):1034–1050
  29. Pericak-Vance MA, Grubber J, Bailey LR, Hedges D, West S, Santoro L, et al. Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol. 2000;35(9–10):1343–1352
  30. Prince JA, Feuk L, Gu HF, Johansson B, Gatz M, Blennow K, et al. Genetic variation in a haplotype block spanning IDE influences Alzheimer disease. Hum Mutat. 2003;22(5):363–371
  31. Prince JA, Feuk L, Howell WM, Jobs M, Emahazion T, Blennow K, et al. Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. Genome Res. 2001;11(1):152–162
  32. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995;376(6543):775–778
  33. Sakai A, Ujike H, Nakata K, Takehisa Y, Imamura T, Uchida N, et al. No association between the insulin degrading enzyme gene and Alzheimer's disease in a Japanese population. Am J Med Genet B Neuropsychiatr Genet. 2004;125(1):87–91
  34. Scott WK, Hauser ER, Schmechel DE, Welsh-Bohmer KA, Small GW, Roses AD, et al. Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22. Am J Hum Genet. 2003;73(5):1041–1051
  35. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995;375:754–760
  36. Sillen A, Forsell C, Lilius L, Axelman K, Bjork BF, Onkamo P, et al. Genome scan on Swedish Alzheimer's disease families. Mol Psychiatry. 2006;11(2):182–186
  37. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68(4):978–989

PII: S0197-4580(06)00229-6

doi: 10.1016/j.neurobiolaging.2006.06.017

Neurobiology of Aging
Volume 28, Issue 9 , Pages 1374-1380 , September 2007

Article Tools